Cargando…
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
Monoclonal antibodies and antibody cocktails are a promising therapeutic and prophylaxis for coronavirus disease 2019 (COVID-19). However, ongoing evolution of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) can render monoclonal antibodies ineffective. Here, we completely map all of th...
Autores principales: | Starr, Tyler N., Greaney, Allison J., Dingens, Adam S., Bloom, Jesse D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020059/ https://www.ncbi.nlm.nih.gov/pubmed/33842902 http://dx.doi.org/10.1016/j.xcrm.2021.100255 |
Ejemplares similares
-
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
por: Starr, Tyler N., et al.
Publicado: (2021) -
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
por: Chen, Peter, et al.
Publicado: (2020) -
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
por: Jones, Bryan E., et al.
Publicado: (2021) -
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
por: Westendorf, Kathryn, et al.
Publicado: (2022) -
An antibody-escape calculator for mutations to the SARS-CoV-2 receptor-binding domain
por: Greaney, Allison J., et al.
Publicado: (2021)